Table 2.
The characteristics of TCGA cases.
Characteristic | TCGA-05-4402 | TCGA-05-4424 | TCGA-05-5425 | TCGA-49-6742 | TCGA-73-A9RS |
---|---|---|---|---|---|
Gender | Female | Male | Male | Male | Male |
Age | 57 | 70 | 68 | 70 | 41 |
Pathologic stage | Stage IV | Stage IIB | Stage IIB | Stage IIA | Stage IIB |
Primary diagnosis | Adenocarcinoma with mixed subtypes | Adenocarcinoma with mixed subtypes | Adenocarcinoma with mixed subtypes | Mucinous adenocarcinoma | Adenocarcinoma, NOS |
Site of resection or biopsy | Lower lobe, lung | Upper lobe, lung | Lung, NOS | Upper lobe, lung | Upper lobe, lung |
Therapy drug name | Erlotinib | Erlotinib | Gefitinib Erlotinib |
MDX-1106 clinical trial | Bevacizumab |
Vital status | Dead | Alive | Alive | Dead | Dead |